Inhibition of human recombinant T-type calcium channels by the endocannabinoid N-arachidonoyl dopamine

British Journal of Pharmacology

Volumn 156, Issue 5, 2009, Pages 740-750

  Ross, Hamish R ^a   Gilmore, Andrew J ^a   Connor, Mark ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Acyl amino acid; Anandamide; Arachidonoyl amino acid; Endocannabinoid; Endovanilloid; N arachidonoyl glycine; NADA; Nociception; T type calcium channel

Indexed keywords

ANANDAMIDE; CALCIUM CHANNEL T TYPE; ENDOCANNABINOID; N ARACHIDONOYLDOPAMINE; N ARACHIDONOYLGLYCINE; UNCLASSIFIED DRUG; ANALGESIC AGENT; ARACHIDONIC ACID DERIVATIVE; ARACHIDONYL DOPAMINE; CALCIUM CHANNEL BLOCKING AGENT; DOPAMINE; DRUG DERIVATIVE; GLYCINE; N ARACHIDONYLGLYCINE; N-ARACHIDONYLGLYCINE; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSORY NERVE CELL; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL MEMBRANE POTENTIAL; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; KINETICS; PATCH CLAMP; PHYSIOLOGY; SENSORY RECEPTOR; TRIGEMINUS GANGLION;

ANALGESICS; ANIMALS; ARACHIDONIC ACIDS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, T-TYPE; CELLS, CULTURED; DOPAMINE; ENDOCANNABINOIDS; GLYCINE; HUMANS; KINETICS; MALE; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; PATCH-CLAMP TECHNIQUES; RECOMBINANT PROTEINS; SENSORY RECEPTOR CELLS; TRIGEMINAL GANGLION;

EID: 66949171814     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2008.00072.x     Document Type: Article

References (47)

1. Alexander SPH, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edition (2008 revision). Br J Pharmacol 153 (Suppl. 2 S1 S209.
2. 1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. Biochem J 351 : 817 824.
3. Borgland SL, Connor M, Christie MJ (2001). Nociceptin inhibits calcium channel currents in a subpopulation of small nociceptive trigeminal ganglion neurons in mouse. J Physiol 536 : 35 47.
4. Burstein SH, Rossetti RG, Yagen B, Zurier RB (2000). Oxidative metabolism of anandamide. Prostaglandins Other Lipid Mediat 61 : 29 41.
5. Burstein SH, Adams JK, Bradshaw HB, Fraioli C, Rossetti RG, Salmonsen RA et al. (2007). Potential anti-inflammatory actions of the elmiric (lipoamino) acids. Bioorg Med Chem 15 : 3345 3355.
6. Chemin J, Monteil A, Perez-Reyes E, Nargeot J, Lory P (2001). Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. EMBO J 20 : 7033 7040.
7. Chemin J, Nargeot J, Lory P (2007). Chemical determinants involved in anandamide-induced inhibition of T-type calcium channels. J Biol Chem 282 : 2314 2323.
8. Chu CJ, Huang SM, De Petrocellis L, Bisogno T, Ewing SA, Miller JD et al. (2003). N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia. J Biol Chem 278 : 13633 13639.
9. 2+ channel gene family. Circ Res 83 : 103 109.
10. V3.1c, a T-type calcium channel from human brain. FEBS Lett 466 : 54 58.
11. De Petrocellis L, Bisogno T, Davis JD, Pertwee RG, Di Marzo V (2000). Overlap between the ligand recognition properties of the anandamide transporter and the VR1 receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett 483 : 52 56.
12. Docherty RJ, Yeats JC, Piper AC (1997). Capsazepine block of voltage-activated calcium channels in adult dorsal root ganglion neurones in culture. Br J Pharmacol 121 : 1461 1467.
13. V3.3: insights into prepulse facilitation. Biophys J 83 : 229 241.
14. Guo J, Williams DJ, Ikeda SR (2008). N-arachidonyl serine, a putative endocannabinoid, alters the activation of N-type calcium channels in sympathetic neurons. J Neurophysiol 100 : 1147 1151.
15. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ (1981). Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391 : 85 100.
16. Heady TN, Gomora JC, MacDonald TL, Perez-Reyes E (2001). Molecular pharmacology of T-type calcium channels. Jpn J Pharmacol 85 : 339 350.
17. q/11-coupled muscarinic acetylcholine receptors. J Biol Chem 282 : 21043 21055.
18. Huang SM, Walker JM (2006). Enhancement of spontaneous and heat-evoked activity in spinal nociceptive neurons by the endovanilloid/endocannabinoid N-arachidonyldopamine (NADA). J Neurophysiol 95 : 1207 1212.
19. Huang SM, Bisogno T, Petros TJ, Chang S-Y, Zavitsanos PA, Zipkin RE et al. (2001). Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J Biol Chem 276 : 42639 42634.
20. Huang SM, Bisogno T, Trevisani M, Al-Hayani A, de Petrocellis L, Fezza F et al. (2002). An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid receptors. Proc Natl Acad Sci USA 99 : 8400 8405.
21. Iftinca M, Hamid J, Chen L, Varela D, Tadayonnejad R, Altier C et al. (2007). Regulation of T-type calcium channels by Rho-associated kinase. Nat Neurosci 10 : 854 860.
22. Kohno M, Hasegawa H, Inoue A, Muraoka M, Miyazaki T, Oka K et al. (2006). Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18. Biochem Biophys Res Commun 347 : 827 832.
23. Lundbaek JA (2008). Lipid bilayer-mediated regulation of ion channel function by amphiphilic drugs. J Gen Physiol 131 : 421 429.
24. Lundbaek JA, Birn P, Girshman J, Hansen AJ, Andersen OS (1996). Membrane stiffness and channel function. Biochemistry 35 : 3825 3830.
25. Lundbaek JA, Birn P, Hansen AJ, Sogaard R, Nielsen C, Girshman J et al. (2004). Regulation of sodium channel function by bilayer elasticity: the importance of hydrophobic coupling. Effects of micelle-forming amphiphiles and cholesterol. J Gen Physiol 123 : 599 621.
26. Marinelli S, Di Marzo V, Florenzano F, Fezza F, Viscomi MT, van der Stelt M et al. (2007). N-arachidonoyl-dopamine tune synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors. Neuropsychopharmacology 32 : 298 308.
27. Milman G, Maor Y, Abu-Lafi S, Horowitz M, Gallily R, Baktai S et al. (2006). N-arachidonyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties. Proc Natl Acad Sci USA 103 : 2428 2433.
28. O'Sullivan SE, Kendall DA, Randall MD (2004). Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA). Br J Pharmacol 141 : 803 812.
29. Oh DY, Yoon JM, Moon MJ, Hwang J-I, Choe H, Lee JE et al. (2008). Identification of farnesyl pyrophosphate and N-arachidonylglycine as endogenous ligands for GPR92. J Biol Chem 283 : 21054 21064.
30. Perez-Reyes E (2003). Molecular physiology of low-voltage-activated T-type calcium channels. Physiol Rev 83 : 117 161.
31. Price TJ, Patwardhan A, Akopian AN, Hargreaves KM, Flores CM (2004). Modulation of trigeminal sensory neurons activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide. Br J Pharmacol 141 : 1118 1130.
32. Rimmerman N, Bradshaw HB, Hughes HV, Chen JS-C, Hu SS-J, McHugh D et al. (2008). N-Palmitoyl glycine, a novel endogenous lipid that acts as a modulator of calcium influx and nitric oxide production in sensory neurons. Mol Pharmacol 74 : 213 224.
33. Roberts LA, Christie MJ, Connor M (2002). Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons. Br J Pharmacol 137 : 421 428.
34. Roberts LA, Ross HR, Connor M (2008). Methanandamide activation of a novel current in mouse trigeminal ganglion sensory neurons in vitro. Neuropharmacology 54 : 172 180.
35. 9-Tetrahydrocannabinol and cannabidiol. J Biol Chem 283 : 16124 16134.
36. 1 receptor-mediated effects of the endovanilloid/ endocannabinoid N-arachidonoyl-dopamine on primary afferent fibre and spinal cord neuronal responses in the rat. Eur J Neurosci 20 : 175 184.
37. Saghatelian A, McKinney MK, Bandell M, Patapoutian A, Cravatt BF (2006). A FAAH-regulated class of N-acyl taurines that activates TRP ion channels. Biochemistry 45 : 9007 9015.
38. Sheskin T, Hanus L, Slager J, Vogel Z, Mechoulam R (1997). Structural requirements for binding of anandamide-type compounds to the rat brain cannabinoid receptor. J Med Chem 40 : 659 667.
39. Shin H-S, Cheong E-J, Choi S, Lee J, Na HS (2008). T-type calcium channels as therapeutic targets in the nervous system. Curr Opin Pharmacol 8 : 33 41.
40. Succar R, Mitchell VA, Vaughan CW (2007). Actions of N-arachidonyl- glycine in a rat inflammatory pain model. Mol Pain 3 : 24.
41. 1g. J Gen Physiol 124 : 225 238.
42. V3.2 T-type calcium channels. Mol Pharmacol 73 : 1596 1609.
43. Tian X, Guo J, Yao F, Yang D-P, Makriyannis A (2005). The conformation, location and dynamic properties of the endocannabinoid ligand anandamide in a membrane bilayer. J Biol Chem 280 : 29788 29795.
44. Vuong LAQ, Mitchell VA, Vaughan CW (2008). Actions of N-arachidonyl-glycine in a rat neuropathic pain model. Neuropharmacology 54 : 189 193.
45. Wiles AL, Pearlman RJ, Rosvall M, Aubrey K, Vandenberg RJ (2006). N-arachidonyl glycine inhibits the glycine transporter, GLYT2a. J Neurochem 99 : 781 786.
46. Yang Z, Aubrey KR, Alroy I, Harvey RJ, Vandenberg RJ, Lynch JW (2008). Subunit-specific modulation of glycine receptors by cannabinoids and N-arachidonyl-glycine. Biochem Pharmacol 76 : 1014 1023.
47. Zhang Y, Cribbs L, Satin J (2000). Arachidonic acid modulation of α1H, a cloned human T-type calcium channel. Am J Physiol Heart Circ Physiol 278 : H184 H193.